Scrip Reports has released a new business report entitled RNAi: The Revolution in Drug Discovery, which includes a review and analysis of the gene silencing technology.
According to Scrip, the report addresses such issues as the advantages of using RNAi in drug discovery, the major industry players, how the technology compares to antisense, and the importance of off-target effects.
Details on obtaining the report can be found at pjbpubs.com/cms.asp?pageid=1393.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
